Back Health Care and Information

GTx Submits NDA For Toremifene 80 Mg For Prevention Of Bone Fractures In Men With Prostate Cancer On Androgen Deprivation Therapy

admin — Tue, 06 Jan 2009 08:01:36 +0000

GTx, Inc. (Nasdaq: GTXI) announced the submission of a New Drug Application with the U.S. Food and Drug Administration (FDA) for toremifene 80 mg, an oral selective estrogen receptor modulator (SERM), for the prevention of bone fractures in men with prostate cancer on androgen deprivation therapy (ADT). “ADT has helped improve survival for men with advanced prostate cancer.

More: continued here

Unicompartmental As Good Total Knee Replacement At 15 Years

admin — Tue, 06 Jan 2009 11:01:52 +0000

A study published in The Journal of Bone and Joint Surgery, British Volume has summarised the results from a 15 year follow-up of a randomised trial that took place between 1989 and 1992 whereby 102 knees we given either a unicompartmental knee replacement (UKR) or a total knee replacement (TKR).

More: continued here

Treating Femoral Fractures With Limited Resources

admin — Tue, 06 Jan 2009 08:01:45 +0000

An article published in The Journal of Bone and Joint Surgery, British Volume demonstrates that in cases where resources are limited and there is a delay from injury to treatment, femoral fractures can heal successfully without stabilisation by external or internal fixation.

More: continued here

DiFUSION To Mitigate Surgical Site Infections That Affect An Estimated 780,000 Patients In The USA Each Year

admin — Tue, 06 Jan 2009 02:01:33 +0000

DiFUSION Technologies, Inc., a medical device company targeting the orthopaedic market, today announced its corporate launch. The company will focus on reducing the rising incidence of Surgical Site Infections (SSIs) in spinal surgeries. “In large studies, five out of 100 spine cases result in SSIs often leading to second surgeries that are extremely costly and difficult for the patient,” said Dr.

More: continued here

Osteoporosis Drug Linked To Bone Death In Jaw

admin — Mon, 05 Jan 2009 04:01:00 +0000

A new US study found that even short term use of oral bisphosphonates like Fosomax (alendronate), commonly used to treat osteoporosis, may leave the jaw vulnerable to devastating necrosis (death of bone tissue).

More: continued here

Replacing Your Total Hip Replacement

admin — Mon, 05 Jan 2009 05:01:57 +0000

Each year thousands of patients undergo total hip replacement surgery in order to help alleviate pain associated with debilitating hip disease and other related hip problems. According to a new study published in the January 2009 issue of The Journal of Bone and Joint Surgery (http://www.ejbjs.

More: continued here

Parkinson’s Disease Plays Havoc With Common Orthopaedic Conditions

admin — Mon, 05 Jan 2009 04:01:30 +0000

Although Parkinson’s disease (PD) is a neurological disorder, according to an article in the January 2009 issue of the Journal of the American Academy of Orthopaedic Surgeons, the disease also increases a person’s risk of experiencing complicated orthopaedic conditions. The author recommends that all Parkinson’s treatment plans include a multidisciplinary approach in order to address additional accompanying musculoskeletal health issues. According to the author Lee M.

More: continued here

MRI Emerges As Vital Resource In Treatment Of Back Pain

admin — Mon, 05 Jan 2009 02:01:54 +0000

Magnetic resonance imaging (MRI) is a growing technology providing an increasing number of clinical benefits when used in the evaluation of back pain according to an article in the January 2009 issue of the Journal of the American Academy of Orthopaedic Surgeons (http://www.jaaos.org).

More: continued here

GTx Submits New Drug Application For Toremifene 80 Mg For Prevention Of Bone Fractures In Men With Prostate Cancer On Androgen Deprivation Therapy

admin — Sat, 03 Jan 2009 02:01:38 +0000

GTx, Inc. (Nasdaq: GTXI) today announced the submission of a New Drug Application with the U.S. Food and Drug Administration (FDA) for toremifene 80 mg, an oral selective estrogen receptor modulator (SERM), for the prevention of bone fractures in men with prostate cancer on androgen deprivation therapy (ADT). “ADT has helped improve survival for men with advanced prostate cancer.

More: continued here

Singapore Is First In Asia To Use Limb-lengthening Technology For Those Wanting To Be Taller

admin — Fri, 02 Jan 2009 09:01:03 +0000

It was initially devised as a method of leg lengthening for those with congenital growth abnormalities or trauma to the lower limbs. However, since it was introduced in 2001, Fitbone surgery has without much fanfare, slipped into the realm of cosmetics.

More: continued here